← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

#	Name	Funds holding	Growth	Growth %	Fund value
1	1 Pfizer PFE $166B	2,050	-25	-1%	$141B
2	2 Amgen AMGN $230B	1,596	-5	-0.3%	$99.4B
3	3 Eli Lilly LLY $1.08T	1,247	-3	-0.2%	$69.4B
4	4 Becton Dickinson BDX $51.5B	1,079	+13	+1%	$39.2B
5	5 McKesson MCK $114B	909	+19	+2%	$29.9B
6	6 Conagra Brands CAG $6.61B	674	-21	-3%	$11.9B
7	7 Teva Pharmaceutical Industries Limited TEVA $47.5B	650	-38	-6%	$19.6B
8	8 Regeneron Pharmaceuticals REGN $80.1B	604	+25	+4%	$35.9B
9	9 Novo Nordisk NVO $168B	484	+21	+5%	$6.59B
10	10 DaVita DVA $11.5B	477	-5	-1%	$10.6B
11	11 Lamb Weston LW $7.31B	470	+18	+4%	$5.21B
12	12 AstraZeneca AZN $251B	467	+5	+1%	$12.3B
13	13 ResMed RMD $33.1B	340	-35	-9%	$6.76B
14	14 West Pharmaceutical WST $26.4B	310	+15	+5%	$6.36B
15	15 Accendra Health ACH $24.1M	273	-11	-4%	$1.95B
16	16 DELISTED CATALENT, INC. CTLT	241	+32	+15%	$4.43B
17	17 Opko Health OPK $1.02B	232	-13	-5%	$855M
18	18 Herbalife HLF $1.49B	207	+6	+3%	$7.18B
19	19 Fresenius Medical Care FMS $11.5B	189	+3	+2%	$774M
20	20 Tootsie Roll Industries TR $2.87B	172	-1	-0.6%	$479M
21	21 Medifast MED $132M	161	-6	-4%	$443M
22	22 DELISTED WW International WW	151	+13	+9%	$1.91B
23	23 Lexicon Pharmaceuticals LXRX $712M	136	-1	-0.7%	$1.89B
24	TWNK 24 DELISTED Hostess Brands, Inc. Class A Common Stock TWNK	134	+20	+18%	$1.63B
25	25 Dr. Reddy's Laboratories RDY $10.6B	128	-6	-4%	$1.07B